[Molecular subtypes and perspectives of targeted therapies in prostate cancer]

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Advancements in high-throughput molecular technologies offer deep insights into cancer biology.
• Large-scale patient sample analyses have generated extensive data on cancer's genetic, epigenetic, transcriptomic, and proteomic landscape.
• Translational research aims to convert these findings into clinical therapeutic strategies.

Purpose of the Study:

• To review current progress in primary and metastatic prostate cancer research.
• To focus on molecular subtype classification and frequently dysregulated pathways in prostate cancer.
• To highlight approved and investigational therapies for prostate cancer.

Main Methods:

• Review of recent high-throughput molecular studies in prostate cancer.
• Analysis of molecular alterations and affected pathways.
• Compilation of information on therapeutic strategies.

Main Results:

• Identification of frequent molecular alterations and pathways driving prostate cancer formation and progression.
• Characterization of molecular subtypes within prostate cancer.
• Overview of dysregulated pathways including androgen signaling, PI3K pathway, cell cycle, and DNA repair.

Conclusions:

• Molecular insights are rapidly advancing prostate cancer understanding and treatment.
• Identification of key pathways and subtypes guides therapeutic development.
• Ongoing research holds promise for significant changes in clinical practice for prostate cancer patients.